Don't disagree with risk-based approach but how precautionary, when?
But surely some areas, such as products directly in contact with children should have a more precautionary approach in such areas. This was a known carcinogen, not a speculative area.
CONTEXT(Help)
-
MATTER Walking with Stakeholders on new technologies »MATTER Walking with Stakeholders on new technologies
▲
METHODOLOGY »METHODOLOGY
▲
STAKEHOLDER ENGAGEMENT  »STAKEHOLDER ENGAGEMENT
▲
Stakeholders engaged »Stakeholders engaged
▲
NGOs and consumer groups »NGOs and consumer groups
▲
David Santillo, Greenpeace »David Santillo, Greenpeace
▲
Conversation log »Conversation log
▲
Lack of available data on HSE in public domain raises questions »Lack of available data on HSE in public domain raises questions
▲
It is very difficult to get data on such areas even in public interest »It is very difficult to get data on such areas even in public interest
▲
Why are companies unwilling to share info on testing if prod is safe »Why are companies unwilling to share info on testing if prod is safe
■
Don't disagree with risk-based approach but how precautionary, when?
●
In this instance there were easy alternatives »In this instance there were easy alternatives
●
Problem = when risks being research with products on the market »Problem = when risks being research with products on the market
+Comments (0)
+Citations (0)
+About